Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.
Dytfeld
Dominik
D
Matuszak
Magdalena
M
Lewandowski
Krzysztof
K
Komarnicki
Mieczysław
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D010954:Plasmacytoma / Q000000981:diagnostic imaging / Q000628:therapy*; D011719:Pyrazines / Q000008:administration & dosage; D011859:Radiography; D012074:Remission Induction; D013125:Spinal Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D013792:Thalidomide / Q000008:administration & dosage; D014182:Transplantation, Autologous
D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone